The PennZone

  • Home
  • Non-profit
  • Entertainment
  • Business
  • Construction
  • Education
  • Technology
  • Real Estate
  • Celebrities

CPC Scientific Announces New California Peptide API Manufacturing Facility
The PennZone/10188374

Trending...
  • From Speech Therapy to 300+ Episodes: Brother Marcus Turns His Voice Into a Movement Launching a 24/7 Inspiration Radio Network on Day 100 of the Year
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Porter's Day Care Empowers Philadelphia's Future Through 45+ Years of Excellence
CPC Scientific Inc.
SAN JOSE, Calif. - PennZone -- CPC Scientific Inc., a leading global peptide CRDMO (Contract Research, Development, and Manufacturing Organization) has invested in a new peptide API (Active Pharmaceutical Ingredient) manufacturing site, bringing many new jobs to Rocklin, California. The 41,000 sq ft facility located at 3880 Atherton Rd, Rocklin, CA 95765 will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity and will diversify CPC Scientific's supply chain.

"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.

Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.

More on The PennZone
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
  • Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
  • Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
  • RemodelCalculators.com Launches 15 Free Home Renovation Tools

Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.

"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.

More on The PennZone
  • InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
  • CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
  • Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
  • Bishop Mary's WWDB 860 AM Show Nears Historic 250-Episode Milestone
  • Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports

The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.

About CPC Scientific.

Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).

Contact
Chris Gothard, Ph.D.
***@cpcscientific.com
408-734-3800


Source: CPC Scientific Inc.

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • UK Buyers Purchase Luxury Home in Keene's Pointe, Windermere (Orlando, Florida)
  • Instant IP Launches Rapid Takedown Service to Combat IP Theft, Deepfakes, and Copycat Websites
  • From Speech Therapy to 300+ Episodes: Brother Marcus Turns His Voice Into a Movement Launching a 24/7 Inspiration Radio Network on Day 100 of the Year
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Best Companies Group Launches Free Best Places to Work in Chicago Program
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
  • This Saturday: Open House for Manalapan's Newest Single Family Home Community
  • Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions
  • MainConcept and NETINT Bring VPU Acceleration to Easy Video API
  • Dr. Roxanne Contee Continues to Shine as a Powerhouse in Philadelphia Fashion, Media, and Community
  • Larry R. Wasion's Jump Gate 2: Teleporter Expands the Time Travel Universe with High-Stakes Action and Ethical Dilemmas
  • Bruce A. Rosenblat Releases A Pocket Full of Change, a Sharp, Thought-Provoking Book on Growth, Perspective, and Personal Change
  • Marcus Boyd Announces Upcoming Children's Book The Royal World of Autism and Expands His Global Advocacy for Autism Awareness
  • Former Philly Athletes Support Special Needs, Local Woman at Foundation Golf Classic
  • Phuket Bike Week Rebrands as Hard Rock Cafe Phuket Bike Week Under Landmark 5-Year Partnership
  • L2 Aviation Appoints Tony Bailey as President and Chief Operating Officer
  • Pieter Bouterse Studio Founder to Retire After 40+ Years; Seeks Successor to Continue Legacy
  • #WeAreGreekWarriors Opening Reception Packs the House
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)

Popular on PennZone

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 205
  • Actress/Model Raelia Lewis Building a Powerful Name in Entertainment and Fashion - 108
  • R&B Artist Mike Davis Announces Debut Full-Length Album Full Circle, Releasing April 7
  • 300 Episodes. One Mission: Brother Marcus Ignites a Global Movement of Inspiration
  • New Report Reveals Surprising Trends in Ohio Airport Accidents
  • Bethany Nikitenko Elected Board Vice President of Philadelphia VIP
  • From Speech Therapy to 300+ Episodes: Brother Marcus Turns His Voice Into a Movement Launching a 24/7 Inspiration Radio Network on Day 100 of the Year
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • Scoop Social Co. Launches a New Era of Mobile Hospitality — One Truck, Two Experiences
  • IWS Press Publishes "Smart Money Shortcuts to Becoming Rich" by Tyler G. Hicks

Similar on PennZone

  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
  • CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
  • Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
  • Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
  • YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
  • Instant IP Launches Rapid Takedown Service to Combat IP Theft, Deepfakes, and Copycat Websites
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us